Sales in the domestic market are expected to be impacted in Q2 by the revision in GST rates, as distributors focused on ...

In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell unauthorized versions undermines these rights.

Aurinia Pharmaceuticals has strong Lupkynis sales, robust pipeline, and financial health drive growth. See why we rate AUPH ...

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...

These issues had contributed to high turnover and low morale. The challenge, then, was not merely to bring structure to the ...

Oct. 14, days before the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Merck & Co. | Merck has just ...

The negative readout led to a collapse in share price for Alector, which now plans to cut almost half of its workforce while ...

Alector Therapeutics is shelving a GSK-partnered antibody after the asset failed to slow disease progression in patients with ...

As the pharmaceutical sector grows in India, Jamkas Pharmaceuticals emerges as a reliable third-party manufacturer.

As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop ...

President Donald Trump is working on a deal with major pharmaceutical companies, including Pfizer, to lower the cost of ...